• Wiley Online Library will be disrupted on 18 May from 10:00-12:00 BST (05:00-07:00 EDT) for essential maintenance
  • Please log in or register to access this feature.

Supplement

You have full text access to this OnlineOpen article

Pathology and classification of ovarian tumors†

  1. Vivien W. Chen Ph.D.1,
  2. Bernardo Ruiz M.D., Ph.D.1,
  3. Jeffrey L. Killeen M.D.2,
  4. Timothy R. Coté M.D., M.P.H.3,
  5. Xiao Cheng Wu M.D., M.P.H., C.T.R.1,
  6. Catherine N. Correa Ph.D.1,
  7. Holly L. Howe Ph.D.‡,*

Article first published online: 30 APR 2003

DOI: 10.1002/cncr.11345

Issue

Cancer

Cancer

Supplement: North American Association of Central Cancer Registries

Volume 97, Issue Supplement 120, pages 2631–2642, 15 May 2003

Additional Information

How to Cite

Chen, V. W., Ruiz, B., Killeen, J. L., Coté, T. R., Wu, X. C., Correa, C. N. and Howe, H. L. (2003), Pathology and classification of ovarian tumors. Cancer, 97: 2631–2642. doi: 10.1002/cncr.11345

Author Information

  1. 1

    Louisiana Tumor Registry, Louisiana State University Health Sciences Center, New Orleans, Louisiana

  2. 2

    Kapiolani Medical Center for Women and Children, Honolulu, Hawaii

  3. 3

    National Cancer Institute, Bethesda, Maryland

  1. ‡

    Fax: (217) 698-0188

*North American Association of Central Cancer Registries, 2121 White Oaks Dr., Springfield, IL 62704

  1. †

    This article is a US Government work and, as such, is in the public domain of the United States of America.

  2. ‡

    Fax: (217) 698-0188

Publication History

  1. Issue published online: 30 APR 2003
  2. Article first published online: 30 APR 2003
  3. Manuscript Accepted: 15 JAN 2003
  4. Manuscript Revised: 25 SEP 2002
  5. Manuscript Received: 18 MAR 2002

Funded by

  • Centers for Disease Control and Prevention. Grant Number: U75/CCU515998

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (141K)

REFERENCES

  • 1
    Adashi E, Leung P. The ovary. Philadelphia: Lippincott Williams & Wilkins, 1993.
  • 2
    Barber HR. Embryology of the gonad with reference to special tumors of the ovary and testis. J Pediatr Surg. 1988; 23: 967–972.
  • 3
    Gondos B. Development of the reproductive organs. Ann Clin Lab Sci. 1985; 15: 363–373.
  • 4
    Mittwoch U. Males, females and hermaphrodites. Ann Hum Genet. 1985; 50: 103–121.
    Direct Link:
  • 5
    Motta P, Makabe S, Nottola S. The ultrastructure of human reproduction. I. The natural history of the female germ cell: origin, migration and differentiation inside the developing ovary. Hum Reprod Update. 1997; 3: 281–295.
  • 6
    Ostrer H. Sexual differentiation. Semin Reprod Med. 2000; 18: 41–49.
  • 7
    Stenberg S. Histology for pathologists. Philadelphia: Lippincott-Raven, 1997.
  • 8
    Kurman R. Blaustein's pathology of the female genital tract. New York: Springer-Verlag, 1994.
  • 9
    Rubin SC, Sutton G. Ovarian cancer. Philadelphia: Lippincott Williams & Wilkins, 2001.
  • 10
    Scully R, Sobin L. Histological typing of ovarian tumours, volume 9. New York: Springer Berlin, 1999.
  • 11
    Scully R, Young R, Clement P. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. Washington: Armed Forces Institute of Pathology, 1998.
  • 12
    Pettersson F. Annual report of the results of treatment in gynecological cancer. Stockholm: International Federation of Gynecology and Obstetrics, 1991.
  • 13
    Stalsberg H, Bjarnason O, de Carvalho ARL, et al. An international survey of distribution of histologic types of tumors of the testis and ovary. In: StalsbergH, editor. An international survey of distribution of histologic types of tumors of the testis and ovary. UICC technical report series, volume 75. Geneva: International Union Against Cancer, 1983.
  • 14
    Serov SF, Scully RE, Sobin LH. Histological typing of ovarian tumours, volume 9. Geneva: World Health Organization, 1973.
  • 15
    Parkin DM, Shanmugaratnam K, Sobin L, Ferlay J, Whelan SL. Histological groups for comparative studies, volume 31. IARC technical report. Lyon: International Agency for Research on Cancer, 1998.
  • 16
    Fritz A, Percy C, Jack A, et al. International classification of diseases for oncology, 3rd edition. Geneva: World Health Organization, 2000.
  • 17
    Rothwell DJ. Systematized nomenclature of medicine. Microglossary for surgical pathology. Northfield: College of American Pathologists, 1980.
  • 18
    FlemingID, CooperJS, HensonDE, HutterRVP, KennedyBJ, editors. American Joint Committee on Cancer (AJCC) cancer staging manual, 5th edition. Philadelphia: Lippincott-Raven, 1997.
  • 19
    Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. J Epidemiol Biostat. 2001; 6: 107–138.
  • 20
    Shimizu Y, Kamoi S, Amada S, Hasumi K, Akiyama F, Silverberg SG. Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features—problems involved in the architectural grading system. Gynecol Oncol. 1998; 70: 2–12.
  • 21
    Silverberg SG. Histopathologic grading of ovarian carcinoma: a review and proposal. Int J Gynecol Pathol. 2000; 19: 7–15.
  • 22
    Mayr D, Diebold J. Grading of ovarian carcinomas. Int J Gynecol Pathol. 2000; 19: 348–353.
  • 23
    Garcia A, Bussaglia E, Machin P, Matias-Guiu X, Prat J. Loss of heterozygosity on chromosome 17q in epithelial ovarian tumors: association with carcinomas with serous differentiation. Int J Gynecol Pathol. 2000; 19: 152–157.
  • 24
    Russell SE, McIlhatton MA, Burrows JF, et al. Isolation and mapping of a human septin gene to a region on chromosome 17q, commonly deleted in sporadic epithelial ovarian tumors. Cancer Res. 2000; 60: 4729–4734.
  • 25
    Baxter SW, Thomas EJ, Campbell IG. GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer. Carcinogenesis. 2001; 22: 63–65.
  • 26
    Prat J. Ovarian tumors of borderline malignancy (tumors of low malignant potential): a critical appraisal. Adv Anat Pathol. 1999; 6: 247–274.
  • 27
    Szych C, Staebler A, Connolly DC, Wu R, Cho KR, Ronnett BM. Molecular genetic evidence supporting the clonality and appendiceal origin of pseudomyxoma peritonei in women. Am J Pathol. 1999; 154: 1849–1855.
  • 28
    Aunoble B, Sanches R, Didier E, Bignon YJ. Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer. Int J Oncol. 2000; 16: 567–576.
  • 29
    Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst. 1998; 90: 1774–1786.
  • 30
    Auer G, Einhorn N, Nilsson B, Silfversward C, Sjovall K. Biological malignancy grading in early-stage ovarian carcinoma. Acta Oncol. 1996; 35: 93–98.
  • 31
    Costa MJ, Walls J, Ames P, Roth LM. Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIB-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior. Hum Pathol. 1996; 27: 274–281.
  • 32
    Shigemasa K, Shiroyama Y, Sawasaki T, et al. Underexpression of cyclin-dependent kinase inhibitor p27 is associated with poor prognosis in serous ovarian carcinomas. Int J Oncol. 2001; 18: 953–958.
View Full Article (HTML) Get PDF (141K)